Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 19 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

16%

3 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

11 recruiting

Enrollment Performance

Analytics

N/A
7(63.6%)
Phase 4
3(27.3%)
Phase 2
1(9.1%)
11Total
N/A(7)
Phase 4(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT06189924Recruiting

Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients

Role: lead

NCT04226313Not ApplicableRecruiting

Self-sampling for Non-attenders to Cervical Cancer Screening

Role: lead

NCT04157361Recruiting

Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.

Role: lead

NCT04619524Not ApplicableRecruiting

Biomarkers of Endometrial Receptivity

Role: lead

NCT04427163Recruiting

Assesment of Multiomics Profiles in Health and Disease.

Role: lead

NCT07033091Not ApplicableRecruiting

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

Role: lead

NCT06016569Not ApplicableRecruiting

Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.

Role: lead

NCT05774561Recruiting

Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

Role: lead

NCT07387211Not ApplicableCompleted

Study SARS-CoV-2-CZ-PREVAL-II - Arm of the Olomouc Region

Role: lead

NCT07112937Recruiting

The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study

Role: lead

NCT03323346Phase 2Recruiting

Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer

Role: lead

NCT06501521Recruiting

Non-invasive Brain Tumor Molecular Diagnostics and Monitoring

Role: lead

NCT03700541Phase 4Completed

Influence of Opioid Analgesia on Circulating Tumor Cells in Laparoscopic Colorectal Cancer Surgery

Role: lead

NCT03700411Phase 4Completed

Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer Surgery

Role: lead

NCT05096962Completed

COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

Role: collaborator

NCT05619562Completed

Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients

Role: lead

NCT04133610Not ApplicableCompleted

HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs

Role: lead

NCT03337347Not ApplicableCompleted

Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients

Role: lead

NCT02314871Phase 4Completed

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

Role: lead

All 19 trials loaded